Samuel Backenroth's Net Worth

$177 Thousand

Estimate Recalculated Sep 8, 2024 07:25PM EST

Who is Samuel Backenroth?

Samuel Backenroth does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Ohr Pharmaceutical Inc, and Vascular Biogenics Ltd..

SEC CIK

Samuel Backenroth's CIK is 0001579887

Past Insider Trading and Trends

2016 was Samuel Backenroth's most active year for acquiring shares with 20 total transactions. Samuel Backenroth's most active month to acquire stocks was the month of April. 2023 was Samuel Backenroth's most active year for disposing of shares, totalling 1 transactions. Samuel Backenroth's most active month to dispose stocks was the month of February. 2017 saw Samuel Backenroth paying a total of $50,000.30 for 471,430 shares, this is the most they've acquired in one year. In 2023 Samuel Backenroth cashed out on 525,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ohr Pharmaceutical Inc (NBSE) No price found

CFO, Treasurer & Secretary

Samuel Backenroth owns 212,596 units of Common Stock, par value $0.0001 per share and 11,630 units of Common Stock. In the year 2013 Samuel Backenroth acquired a total of 208,897 shares in Ohr Pharmaceutical Inc at a cost of $81,048.75.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 29
Form 4
+9.41%
1K
$6.00
$6,000.00
11.63K
Apr 30
Form 4
—
0
—
—
0
Jul 12
Form 4
—
0
—
—
0
Oct 16
Form 4
+50.60%
71.43K
$0.70
$50,000.30
212.6K
Apr 10
Form 4
+1.78%
2.47K
$2.84
$6,997.44
141.17K
Jun 20
Form 4
+1.84%
2.5K
$3.17
$7,926.01
138.7K
May 23
Form 4
+2,097.11%
130K
—
—
136.2K
Jan 7
Form 4
—
0
—
—
0
Mar 10
Form 4
+31.92%
1.5K
$6.75
$10,125.00
6.2K
Feb 6
Form 4
—
0
—
—
0
Feb 3
Form 3
—
0
—
—
0
No matching records found

Vascular Biogenics Ltd. (NTBL) Snapshot price: $0.4921

Chief Financial Officer

Samuel Backenroth owns 525,000 units of Ordinary Shares which is worth $258,352.50. In the year 2023 Samuel Backenroth filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
525K
—
—
525K
Mar 31
Form 3
—
0
—
—
0
No matching records found